News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Global Commercialization of Applied Biosystems (ABI) 3500 Series Genetic Analyzers Sets New Standards for Throughput, Data Quality and Ease-of-Use



10/22/2009 9:29:44 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use. The 3500 Series Genetic Analyzer is for research use only not intended for therapeutic or diagnostic use.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES